Exploring Development of an In Vitro Bone Marrow Strategy to Recapitulate & Support ADC Toxicity Assessment

  • Delving into the development of a suite of bone marrow in vitro models to utilise in preclinical ADC haematotoxicity assessment
  • Evaluating in vitro model capability to replicate clinical ADC toxicities and support drug development
  • Understanding limitations of ADC in vitro models and exploring future directions to overcome them